Pretreatment EEG in childhood absence epilepsy

Neurology

Volumn 81, Issue 2, 2013, Pages 150-156

  Dlugos, Dennis ^a   Shinnar, Shlomo ^b   Cnaan, Avital ^c   Hu, Fengming ^c   Moshé, Solomon ^b   Mizrahi, Eli ^d   Masur, David ^b   Sogawa, Yoshi ^b   Pichon, J B Le ^d   Levine, Calley ^a   Hirtz, Deborah ^e   Clark, Peggy ^f   Adamson, Peter C ^a   Glauser, Tracy ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; AMBULATORY CARE; ARTICLE; ATTENTION; CHILD; CHILDHOOD ABSENCE EPILEPSY; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PREDICTIVE VALUE; PREMEDICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; VIDEORECORDING;

ADOLESCENT; ANTICONVULSANTS; ATTENTION; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; HUMANS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEIZURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881273612     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829a3373     Document Type: Article

References (18)

1. Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis. Epilepsia 2000;41:1269-1275
2. Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 2001;42:464-475
3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399
4. Loiseau P, Duche B, Pedespan JM. Absence epilepsies. Epilepsia 1995;36:1182-1186
5. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-799
6. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013;54:141-155
7. Bouma PA, Westendorp RG, van Dijk JG, Peters AC, Brouwer OF. The outcome of absence epilepsy: a metaanalysis. Neurology 1996;47:802-808
8. Wirrell EC, Camfield CS, Camfield PR, Dooley JM, Gordon KE, Smith B. Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheeps' clothing. Arch Pediatr Adolesc Med 1997;151:152-158
9. Pavone P, Bianchini R, Trifiletti RR, Incorpora G, Pavone A, Parano E. Neuropsychological assessment in children with absence epilepsy. Neurology 2001;56:1047-1051
10. Conners CK. Conners' Continuous Performance Test II: Technical Guide and Software Manual. North Tonawanda, NY: Multi-Health Systems; 2002
11. Heaton KR, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting TestManual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources; 1993.
12. Rosner B. Fundamentals of Biostatistics, 4th ed. Belmont, CA: Duxbury Press; 1995.
13. Sadleir LG, Farrell K, Smith S, Connolly MB, Scheffer IE. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology 2006;67:413-418
14. Ma M, Zang Y, Yang Z, et al. Childhood absence epilepsy: electroclinical features and diagnostic criteria. Brain Dev 2011;33:114-119
15. Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-836
16. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-979
17. Holmes GL, Frank LM, Sheth RD, et al. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy Res 2008;82:124-132
18. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel group study. Epilepsia 2004;45:1049-1053